IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP

IGF::OT::IGF 任务订单号

基本信息

  • 批准号:
    10373911
  • 负责人:
  • 金额:
    $ 1.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-16 至 2022-03-15
  • 项目状态:
    已结题

项目摘要

The National Institutes of Health (NIH) established the Blueprint Neurotherapeutics Network (BPN) to accelerate the process of discovering and developing new drugs. The BPN supports, through grants and contracts, every step of the drug development process from validated hits through early clinical trials. The Drug Manufacturing and Formulation Program (DMFP), a component of the BPN, conducts the development and manufacture of dosage forms of small molecule drug candidates suitable for administration in preclinical efficacy studies, Investigational New Drug (IND) enabling studies, and clinical trials. Contractors conduct process development and preparation of active pharmaceutical ingredients (API), pre-formulation and formulation studies, analytical method development and validation, stability studies, drug product manufacturing, packaging, labeling, storage, and distribution of the drug products. The work is conducted in accordance with Current Good Manufacturing Practices (cGMP) regulations as required and where appropriate in accordance with Good Laboratory Practice (GLP) regulations. Data and documentation are prepared in a form acceptable to the Food and Drug Administration (FDA) for inclusion in a Drug Master File (DMF), IND application, or New Drug Application (NDA).
美国国立卫生研究院(NIH)建立了蓝图神经治疗网络(BPN),以加速发现和开发新药的过程。BPN通过拨款和合同支持药物开发过程的每一步,从验证成功到早期临床试验。药物制造和配方计划(DMFP)是BPN的一个组成部分,负责开发和制造适合临床前疗效研究、研究性新药(IND)研究和临床试验的小分子候选药物剂型。承包商负责原料药(API)的工艺开发和制备、预制剂和制剂研究、分析方法开发和验证、稳定性研究、药品生产、包装、标签、储存和分销。本工作按照现行良好生产规范(cGMP)的规定进行,并在适当情况下按照良好实验室规范(GLP)的规定进行。数据和文件以食品和药物管理局(FDA)可接受的形式准备,以便纳入药物主文件(DMF), IND申请或新药申请(NDA)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEITH BARNES其他文献

KEITH BARNES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEITH BARNES', 18)}}的其他基金

IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP
IGF::OT::IGF 任务订单号
  • 批准号:
    10586014
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
GANESH (EMORY UNIVERSITY) - MCSP - HIT TO LEAD CHEMISTRY
GANESH(埃默里大学)- MCSP - 引领化学
  • 批准号:
    10881612
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
根据 ID/IQ 合同编号 2 的绩效领域 HIT 领导化学
  • 批准号:
    10719308
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC)
SHAMLOO(斯坦福大学)- MCSP-探索化学(EC)
  • 批准号:
    10720930
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC)
SHAMLOO(斯坦福大学)- MCSP-探索化学(EC)
  • 批准号:
    10938120
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
GANESH (EMORY UNIVERSITY) - MCSP - HIT TO LEAD CHEMISTRY
GANESH(埃默里大学)- MCSP - 引领化学
  • 批准号:
    10719283
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
AL-ALI (UNIVERSITY OF MIAMI, SCHOOL OF MEDICINE) - MCSP - EXPLORATORY CHEMISTRY (EC)
AL-ALI(迈阿密大学医学院)- MCSP - 探索化学 (EC)
  • 批准号:
    10719110
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
AL-ALI (UNIVERSITY OF MIAMI, SCHOOL OF MEDICINE) - MCSP - EXPLORATORY CHEMISTRY (EC)
AL-ALI(迈阿密大学医学院)- MCSP - 探索化学 (EC)
  • 批准号:
    10788086
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)
MCSP TORFP 编号
  • 批准号:
    10285409
  • 财政年份:
    2020
  • 资助金额:
    $ 1.88万
  • 项目类别:
MCSP TORFP NO. NIH-NINDS-20-02: MOURADIAN/DISNEY - BASE EC (PARKINSON'S)
MCSP TORFP 编号
  • 批准号:
    10457230
  • 财政年份:
    2020
  • 资助金额:
    $ 1.88万
  • 项目类别:

相似海外基金

This service is for the contractor to provide support on an ad hoc basis or while serving on NIH Biologics Lead Development Teams (LDTs), which include both SME consultants and Analytical Development.
该服务供承包商临时提供支持,或者在 NIH Biologics Lead Development Team (LDT) 中提供支持,其中包括 SME 顾问和分析开发团队。
  • 批准号:
    10949355
  • 财政年份:
    2023
  • 资助金额:
    $ 1.88万
  • 项目类别:
CONTRACTOR SHALL INTEGRATE THE RESEARCHER AUTHENTICATION/AUTHORIZATION (AUTH) SERVICE (RAS) WITH NIDDK CENTRAL REPOSITORY TO ACCOMMODATE SINGLE SIGN-ON AND LOGIN WORKFLOWS, ALONG WITH ANY ASSOCIATED A
承包商应将研究员身份验证/授权 (AUTH) 服务 (RAS) 与 NIDDK 中央存储库集成,以适应单点登录和登录工作流程以及任何相关的 A
  • 批准号:
    10973393
  • 财政年份:
    2023
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR WILL SUPPORT THE NIDA SUMMER RESEARCH INTERNSHIP PROGRAM BY PROVIDING LOGISTICAL SUPPORT TO MANAGE REIMBURSEMENT OF AUTHORIZED EXPENSES
承包商将通过提供管理授权费用报销的后勤支持来支持 NIDA 夏季研究实习计划
  • 批准号:
    10720939
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR SHALL MAINTAIN AND SUPPORT STUDY DATA INFRASTRUCTURE, DATA MANAGEMENT AND DATA PREPARATION, AND ADVANCED STATISTICAL AND BIOINFORMATICS
承包商应维护和支持研究数据基础设施、数据管理和数据准备以及高级统计和生物信息学
  • 批准号:
    10710597
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR WILL SUPPORT THE NIDA SUMMER RESEARCH INTERNSHIP PROGRAM BY PROVIDING LOGISTICAL SUPPORT TO MANAGE REIMBURSEMENT OF AUTHORIZED EXPENSES FOR INTERNS AND RESEARCH SITES, MANAGING THE TIME
承包商将通过提供后勤支持来支持 NIDA 夏季研究实习计划,以管理实习生和研究中心的授权费用报销、管理时间
  • 批准号:
    10938104
  • 财政年份:
    2022
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR SHALL PROVIDE COMPREHENSIVE CLINICAL SITE AND STUDY MONITORING SERVICES FOR THE NCCIH-FUNDED (PRIMARY OR SECONDARY) EXTRAMURAL CLINICAL
承包商应为 NCCIH 资助的(初级或二级)校外临床提供全面的临床现场和研究监测服务
  • 批准号:
    10673580
  • 财政年份:
    2021
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR SHALL PROVIDE ONGOING DEVELOPMENT, MAINTENANCE, AND PROMOTION OF NCI SPONSORED BEHAVIORAL AND MOBILE HEALTH INITIATIVES.
承包商应提供 NCI 赞助的行为和移动健康计划的持续开发、维护和推广。
  • 批准号:
    10497327
  • 财政年份:
    2021
  • 资助金额:
    $ 1.88万
  • 项目类别:
PROVIDE AN INDEPENDENT SURVEILLANCE OF THE HEALTH STATUS OF RODENTS MAINTAINED IN CONTRACTOR FACILITIES FOR THE AGED RODENT COLONIES. THE EVALUATION T
对老年啮齿动物群的承包商设施中饲养的啮齿动物的健康状况进行独立监测。
  • 批准号:
    10505574
  • 财政年份:
    2021
  • 资助金额:
    $ 1.88万
  • 项目类别:
THE CONTRACTOR SHALL PROVIDE COMPREHENSIVE CLINICAL SITE AND STUDY MONITORING SERVICES FOR THE NCCIH-FUNDED (PRIMARY OR SECONDARY) EXTRAMURAL CLINICAL
承包商应为 NCCIH 资助的(初级或二级)校外临床提供全面的临床现场和研究监测服务
  • 批准号:
    10894583
  • 财政年份:
    2021
  • 资助金额:
    $ 1.88万
  • 项目类别:
PROVIDE AN INDEPENDENT SURVEILLANCE OF THE HEALTH STATUS OF RODENTS MAINTAINED IN CONTRACTOR FACILITIES FOR THE AGED RODENT COLONIES. THE EVALUATION T
对老年啮齿动物群的承包商设施中饲养的啮齿动物的健康状况进行独立监测。
  • 批准号:
    10627725
  • 财政年份:
    2021
  • 资助金额:
    $ 1.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了